Paratek Pharmaceuticals, Inc. Quarterly Return On Assets in % from Q1 2012 to Q2 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Paratek Pharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2012 to Q2 2023.
  • Paratek Pharmaceuticals, Inc. Return On Assets for the quarter ending June 30, 2023 was -40.1 %, a 18.5% increase year-over-year.
  • Paratek Pharmaceuticals, Inc. annual Return On Assets for 2022 was -38.3 %, a 14.3% decline from 2021.
  • Paratek Pharmaceuticals, Inc. annual Return On Assets for 2021 was -33.5 %, a 27.4% increase from 2020.
  • Paratek Pharmaceuticals, Inc. annual Return On Assets for 2020 was -46.2 %, a 5.64% increase from 2019.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2023 -40.1 +9.07 +18.5% Apr 1, 2023 Jun 30, 2023
Q1 2023 -40.8 -8.08 -24.7% Jan 1, 2023 Mar 31, 2023
Q4 2022 -38.3 -4.79 -14.3% Oct 1, 2022 Dec 31, 2022
Q3 2022 -52.5 -22.8 -76.9% Jul 1, 2022 Sep 30, 2022
Q2 2022 -49.1 -18.6 -61% Apr 1, 2022 Jun 30, 2022
Q1 2022 -32.8 +13.1 +28.5% Jan 1, 2022 Mar 31, 2022
Q4 2021 -33.5 +12.7 +27.4% Oct 1, 2021 Dec 31, 2021
Q3 2021 -29.7 +13.7 +31.6% Jul 1, 2021 Sep 30, 2021
Q2 2021 -30.5 +15.4 +33.5% Apr 1, 2021 Jun 30, 2021
Q1 2021 -45.8 +1.83 +3.84% Jan 1, 2021 Mar 31, 2021
Q4 2020 -46.2 +2.76 +5.64% Oct 1, 2020 Dec 31, 2020
Q3 2020 -43.4 +1.64 +3.64% Jul 1, 2020 Sep 30, 2020
Q2 2020 -45.9 -3.49 -8.23% Apr 1, 2020 Jun 30, 2020
Q1 2020 -47.7 -8.18 -20.7% Jan 1, 2020 Mar 31, 2020
Q4 2019 -48.9 -9.41 -23.8% Oct 1, 2019 Dec 31, 2019
Q3 2019 -45.1 -0.53 -1.19% Jul 1, 2019 Sep 30, 2019
Q2 2019 -42.4 +4.85 +10.3% Apr 1, 2019 Jun 30, 2019
Q1 2019 -39.5 +11 +21.8% Jan 1, 2019 Mar 31, 2019
Q4 2018 -39.5 +14.2 +26.5% Oct 1, 2018 Dec 31, 2018
Q3 2018 -44.6 +14.4 +24.5% Jul 1, 2018 Sep 30, 2018
Q2 2018 -47.3 +17.1 +26.5% Apr 1, 2018 Jun 30, 2018
Q1 2018 -50.5 +24.8 +33% Jan 1, 2018 Mar 31, 2018
Q4 2017 -53.7 +27.4 +33.8% Oct 1, 2017 Dec 31, 2017
Q3 2017 -59 +16.9 +22.3% Jul 1, 2017 Sep 30, 2017
Q2 2017 -64.3 +7.67 +10.7% Apr 1, 2017 Jun 30, 2017
Q1 2017 -75.3 -13.3 -21.4% Jan 1, 2017 Mar 31, 2017
Q4 2016 -81.2 -31.1 -62.2% Oct 1, 2016 Dec 31, 2016
Q3 2016 -75.9 -30 -65.3% Jul 1, 2016 Sep 30, 2016
Q2 2016 -72 -31.9 -79.8% Apr 1, 2016 Jun 30, 2016
Q1 2016 -62 -24.5 -65.4% Jan 1, 2016 Mar 31, 2016
Q4 2015 -50 -22.9 -84.1% Oct 1, 2015 Dec 31, 2015
Q3 2015 -45.9 -14.1 -44.1% Jul 1, 2015 Sep 30, 2015
Q2 2015 -40 -12.1 -43.2% Apr 1, 2015 Jun 30, 2015
Q1 2015 -37.5 -6.35 -20.4% Jan 1, 2015 Mar 31, 2015
Q4 2014 -27.2 +16.8 +38.1% Oct 1, 2014 Dec 31, 2014
Q3 2014 -31.8 +1 +3.05% Jul 1, 2014 Sep 30, 2014
Q2 2014 -27.9 -7.6 -37.4% Apr 1, 2014 Jun 30, 2014
Q1 2014 -31.1 -13.3 -74.5% Jan 1, 2014 Mar 31, 2014
Q4 2013 -43.9 -30.8 -234% Oct 1, 2013 Dec 31, 2013
Q3 2013 -32.8 -32.6 -16542% Jul 1, 2013 Sep 30, 2013
Q2 2013 -20.4 -6.61 -48.1% Apr 1, 2013 Jun 30, 2013
Q1 2013 -17.8 -6.82 -61.9% Jan 1, 2013 Mar 31, 2013
Q4 2012 -13.2 Oct 1, 2012 Dec 31, 2012
Q3 2012 -0.2 Jul 1, 2012 Sep 30, 2012
Q2 2012 -13.7 Apr 1, 2012 Jun 30, 2012
Q1 2012 -11 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.